Purification removes synthesis-related impurities such as truncated sequences and residual reagents. Effective purification is essential for achieving reliable performance and supporting downstream therapeutic development.

There is no one-size-fits-all approach. Methods such as HPLC, ion-exchange, and desalting are selected based on sequence length, chemistry, and intended application, balancing purity requirements with scalability.

Higher purity reduces variability and the risk of off-target effects, supporting more consistent biological performance. Appropriate purity levels are a foundational consideration for quality and safety in therapeutic programs.

Scaling requires maintaining sequence fidelity, purity, and batch-to-batch consistency while managing increasing complexity and volume. Proven processes and robust controls are critical as programs advance.

Quality is supported through controlled processes, in-process monitoring, and standardized analytical characterization. This approach helps ensure reproducibility as manufacturing scales.